LWMI
FLNA

Legacy Wealth Management (Idaho)’s Filana Therapeutics FLNA Stock Holding History

Legacy Wealth Management (Idaho)’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$437 Hold
258
– – ﹤0.01% 946
2025
Q4 		$511 Hold
258
– – ﹤0.01% 823
2025
Q3 		$751 Hold
258
– – ﹤0.01% 647
2025
Q2 		$467 Hold
258
– – ﹤0.01% 657
2025
Q1 		$387 Hold
258
– – ﹤0.01% 723
2024
Q4 		$586 Hold
258
– – ﹤0.01% 643
2024
Q3 		$6.5K Buy
+258
New +$5.94K ﹤0.01% 364

Other funds holding FLNA

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Legacy Wealth Management (Idaho)'s FLNA Position: Q1 2026 in Review

Legacy Wealth Management (Idaho) held its Filana Therapeutics (FLNA) position steady in Q1 2026 at 258 shares worth $437. The position accounts for ﹤0.01% of the portfolio, ranked #946.

Legacy Wealth Management (Idaho) first reported a position in FLNA in Q3 2024 and has held it in 7 quarters since. The position peaked at $6.5K in Q3 2024. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • Legacy Wealth Management (Idaho) held 258 shares of Filana Therapeutics worth $437 as of Q1 2026.
  • Legacy Wealth Management (Idaho) left its Filana Therapeutics share count unchanged in Q1 2026.
  • Filana Therapeutics made up ﹤0.01% of Legacy Wealth Management (Idaho)'s portfolio in Q1 2026, its #946 holding.
  • Legacy Wealth Management (Idaho) first reported a position in Filana Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • Legacy Wealth Management (Idaho)'s Filana Therapeutics position peaked at $6.5K in Q3 2024.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Legacy Wealth Management (Idaho)'s 13F filing for Q1 2026, filed 7 May 2026.